Actinium Pharmaceuticals Granted Orphan Designation from the European Medicines Agency for Actimab-A
May 24, 2017 09:22 ET
|
Actinium Pharmaceuticals
- Orphan designation provides increased communication and guidance from regulators and 10-year market exclusivity upon marketing authorization- Actinium’s two leading drug candidates, Iomab-B and...
Actinium Pharmaceuticals to Present Actimab-A Data at the 10th International Symposium on Targeted Alpha Therapy
May 23, 2017 07:30 ET
|
Actinium Pharmaceuticals
- Data from the Company’s Actimab-A program to be presented in the Clinical Experiences session being held on Wednesday, May 31, 2017 - Actinium is a sponsor of the conference...
Actinium Pharmaceuticals Announces Appointment of Hematology Expert Dr. Richard Stone of the Dana-Farber Cancer Institute to its Scientific Advisory Board
May 17, 2017 07:00 ET
|
Actinium Pharmaceuticals
Dr. Stone is a world renowned physician with extensive research and clinical experience focused on refractory leukemia patients and advanced myeloproliferative disordersActinium’s Scientific Advisory...
Actinium Pharmaceuticals Announces Sponsorship of the Acute Leukemia Forum 2017
April 18, 2017 07:00 ET
|
Actinium Pharmaceuticals
- Event to bring together worldwide experts to share and discuss latest research that is influencing treatment and management of patients with acute leukemia - Members of Actinium’s...
Cellular Biomedicine Group (CBMG) Approved to Commence Phase I Trial (CALL-1) for C-CAR011 in Adult Patients with Relapsed or Refractory B-cell Acute Lymphoblastic Leukemia (ALL) in China
January 09, 2017 06:10 ET
|
Cellular Biomedicine Group Inc.
SHANGHAI, China and CUPERTINO, Calif., Jan. 09, 2017 (GLOBE NEWSWIRE) -- Cellular Biomedicine Group Inc. (NASDAQ:CBMG) (“CBMG” or the “Company”), a clinical-stage biomedicine firm engaged in the...
Meet YouTube Star #Liam4DS at Bruins Alum Charity Game; Get your own Fist Bump
November 13, 2014 13:44 ET
|
Massachusetts Down Syndrome Congress
MARLBOROUGH, Mass., Nov. 13, 2014 (GLOBE NEWSWIRE) -- Get your own fist bump from Liam Fitzgerald, the 8-year-old boy with Down syndrome who became a YouTube sensation. Footage of Liam, who has Down...
From Nurse to Patient
February 06, 2014 17:44 ET
|
Genentech
MISSION, KS--(Marketwired - Feb 6, 2014) - (Family Features) Despite her career as a scrub nurse for general cancer surgeries, a personal diagnosis of cancer still came as a surprise.
"It...
Invivoscribe FLT3 Method Patent Claims Upheld
July 16, 2013 00:01 ET
|
Invivoscribe
SAN DIEGO, CA--(Marketwired - Jul 16, 2013) - Invivoscribe Technologies, Inc. ("Invivoscribe") has successfully defended the method claims at the core of international patents covering FLT3...
Invivoscribe Prevails in German District Court (FLT3 Patent Infringement Action)
May 14, 2013 00:01 ET
|
Invivoscribe Technologies, Inc.
SAN DIEGO, CA--(Marketwired - May 14, 2013) - MLL Münchner Leukämielabor GmbH ("MLL") Laboratories has been found guilty of patent infringement in a matter involving FLT3 testing patent...
Hollywood Director Guy Magar Publishes Memoir
May 01, 2012 17:01 ET
|
Author Guy Magar
LOS ANGELES, CA--(Marketwire - May 1, 2012) - Hollywood TV and film director Guy Magar (La Femme Nikita, The A-Team, Battlestar Galactica) shares tales of working with then-23-year-old James...